Meanwhile in NSD tumours, EGFR mutations and copy number gains, in addition to the gains of additional growth factor receptor genes PDGFRB and FGFR4, suggest that this pathway is activated via a different mechanism17,20,21,25,32. This evidence concerns the gene FGFR4 and neoplasm.